Phase 1 study of the histone deacetylase inhibitor entinostat plus clofarabine for poor-risk Philadelphia chromosome-negative (newly diagnosed older adults or adults with relapsed refractory disease) acute lymphoblastic leukemia or biphenotypic leukemia

MLA

B. Douglas Smith, et al. “Phase 1 Study of the Histone Deacetylase Inhibitor Entinostat plus Clofarabine for Poor-Risk Philadelphia Chromosome-Negative (Newly Diagnosed Older Adults or Adults with Relapsed Refractory Disease) Acute Lymphoblastic Leukemia or Biphenotypic Leukemia.” Leukemia Research, vol. 110, Sept. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f926cbafa4bb799e499df79670c49d18&authtype=sso&custid=ns315887.

APA

B. Douglas Smith, Amy E. DeZern, Jackie Greer, Maria R. Baer, Hetty E. Carraway, Yusuke Tomita, Richard Piekarz, Ivana Gojo, Nilanjan Ghosh, Min-Jung Lee, Akira Yuno, Jane B. Trepel, Mark J. Levis, Amanda L. Blackford, Keith W. Pratz, Sunmin Lee, Judith E. Karp, Yazeed Sawalha, Steven D. Gore, & Lia Gore. (2020). Phase 1 study of the histone deacetylase inhibitor entinostat plus clofarabine for poor-risk Philadelphia chromosome-negative (newly diagnosed older adults or adults with relapsed refractory disease) acute lymphoblastic leukemia or biphenotypic leukemia. Leukemia Research, 110.

Chicago

B. Douglas Smith, Amy E. DeZern, Jackie Greer, Maria R. Baer, Hetty E. Carraway, Yusuke Tomita, Richard Piekarz, et al. 2020. “Phase 1 Study of the Histone Deacetylase Inhibitor Entinostat plus Clofarabine for Poor-Risk Philadelphia Chromosome-Negative (Newly Diagnosed Older Adults or Adults with Relapsed Refractory Disease) Acute Lymphoblastic Leukemia or Biphenotypic Leukemia.” Leukemia Research 110 (September). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f926cbafa4bb799e499df79670c49d18&authtype=sso&custid=ns315887.